Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01)

Funding Opportunity RFA-DK-14-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (T2D-GENES) consortium. The AMP T2D-GENES will build on and expand the previous work of the T2D GENES consortium. The aim of the consortium is to characterize the genetic variations in human genomic regions that have been putatively associated with type 2 diabetes (T2D) and conduct follow-up functional studies of particular genetic variants. The data coordinating center for the consortium is being solicited via the companion FOA.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding